MoneyWorks4Me

Lupin informs about press release

12 Nov 2018 Evaluate

Lupin has informed about a Press Release as regards receipt of Establishment Inspection Report from the USFDA, post the completion of a Pre-Approval Inspection for Phenytoin Sodium Extended Release 100 mg capsules, at the Company's Nagpur facility in Maharashtra. The inspection conducted in September 2018 concluded without any observations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..